Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine—Biology Is Still King

Rakhshanda Layeequr Rahman; Alfredo Santillan; Mehran Habibi; Peter Beitsch; Pat Whitworth; Harshini Ramaswamy; Nicole Chmielewski-Stivers; Andrea Menicucci; William Audeh; Joyce O’Shaughnessy

doi:10.3390/ijms26020491

Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine—Biology Is Still King

Rakhshanda Layeequr Rahman
, Alfredo Santillan
, Mehran Habibi
, Peter Beitsch
, Pat Whitworth
, Harshini Ramaswamy
, Nicole Chmielewski-Stivers
, Andrea Menicucci
, William Audeh
, Joyce O’Shaughnessy

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	491
Journal	International Journal of Molecular Sciences
Volume	26
Issue number	2
DOIs	https://doi.org/10.3390/ijms26020491
State	Published - Jan 2025
Externally published	Yes

ASJC Scopus Subject Areas

Catalysis
Molecular Biology
Spectroscopy
Computer Science Applications
Physical and Theoretical Chemistry
Organic Chemistry
Inorganic Chemistry

Keywords

70-gene signature
80-gene signature
cT3
locally advanced disease
molecular subtyping
neoadjuvant chemotherapy (NAC)
pathological Complete Response (pCR)
precision oncology

Access to Document

10.3390/ijms26020491

Cite this

@article{2045b5096f5d4ce79ab6df7c3bd3276d,

title = "Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine—Biology Is Still King",

keywords = "70-gene signature, 80-gene signature, cT3, locally advanced disease, molecular subtyping, neoadjuvant chemotherapy (NAC), pathological Complete Response (pCR), precision oncology",

author = "Rahman, \{Rakhshanda Layeequr\} and Alfredo Santillan and Mehran Habibi and Peter Beitsch and Pat Whitworth and Harshini Ramaswamy and Nicole Chmielewski-Stivers and Andrea Menicucci and William Audeh and Joyce O{\textquoteright}Shaughnessy",

note = "Publisher Copyright: {\textcopyright} 2025 by the authors.",

year = "2025",

month = jan,

doi = "10.3390/ijms26020491",

language = "English",

volume = "26",

journal = "International Journal of Molecular Sciences",

issn = "1661-6596",

number = "2",

}

TY - JOUR

T1 - Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine—Biology Is Still King

AU - Rahman, Rakhshanda Layeequr

AU - Santillan, Alfredo

AU - Habibi, Mehran

AU - Beitsch, Peter

AU - Whitworth, Pat

AU - Ramaswamy, Harshini

AU - Chmielewski-Stivers, Nicole

AU - Menicucci, Andrea

AU - Audeh, William

AU - O’Shaughnessy, Joyce

PY - 2025/1

Y1 - 2025/1

KW - 70-gene signature

KW - 80-gene signature

KW - cT3

KW - locally advanced disease

KW - molecular subtyping

KW - neoadjuvant chemotherapy (NAC)

KW - pathological Complete Response (pCR)

KW - precision oncology

UR - https://www.scopus.com/pages/publications/85216254214

UR - https://www.scopus.com/pages/publications/85216254214#tab=citedBy

U2 - 10.3390/ijms26020491

DO - 10.3390/ijms26020491

M3 - Article

C2 - 39859207

AN - SCOPUS:85216254214

SN - 1661-6596

VL - 26

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

IS - 2

M1 - 491

ER -

Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine—Biology Is Still King

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this